신장이식 면역억제요법 가이드라인 개발을 위한 권고안 적용 범위 및 핵심질문 선정
Formulation of the Scope and Key Questions of the Guideline Recommendations for Immunosuppressive Treatment in Kidney Transplantation
1
조회
0
다운로드
3
인용
0
참고문헌
키워드
초록
Background: Although a growing number of guidelines and clinical researches are available for immunosuppressive treatment of post-transplantation, there is no clinical practice guideline for the care of kidney transplant recipients in Korea. Selection of a researchable question is the most important step in conducting qualified guideline development. Thus, we aimed to formulate key questions for Korean guideline to aid clinical decision-making for immunosuppressive treatment. Methods: Based on previous published guidelines review, a first survey was constructed with 29 questions in the range of immunosuppressive treatments. The experts were asked to rate the clinical importance of the question using a 5-point Likert scale. The questions reached 60% or more from the first survey and additional new questions were included in the second survey. In analyzing the responses to items rated on the 9-point scale, consensus agreement on each question was defined as 75% or more of experts rating 7 to 9. Results: In the first survey, 50 experts were included. Among the 29 questions, 27 were derived to get 60% or more importance and 3 new questions were additionally identified. Through the second survey, 9 questions were selected that experts reached consensus on 75% and over of the options. Finally, we developed key questions using PICO (patient, intervention, comparison, and outcome) methodology. Conclusion: The experts reached a high level of consensus on many of key questions in the survey. Final key questions provide direction for developing clinical practice guideline in the immunosuppressive treatment of transplantation.
Abstract
Background: Although a growing number of guidelines and clinical researches are available for immunosuppressive treatment of post-transplantation, there is no clinical practice guideline for the care of kidney transplant recipients in Korea. Selection of a researchable question is the most important step in conducting qualified guideline development. Thus, we aimed to formulate key questions for Korean guideline to aid clinical decision-making for immunosuppressive treatment. Methods: Based on previous published guidelines review, a first survey was constructed with 29 questions in the range of immunosuppressive treatments. The experts were asked to rate the clinical importance of the question using a 5-point Likert scale. The questions reached 60% or more from the first survey and additional new questions were included in the second survey. In analyzing the responses to items rated on the 9-point scale, consensus agreement on each question was defined as 75% or more of experts rating 7 to 9. Results: In the first survey, 50 experts were included. Among the 29 questions, 27 were derived to get 60% or more importance and 3 new questions were additionally identified. Through the second survey, 9 questions were selected that experts reached consensus on 75% and over of the options. Finally, we developed key questions using PICO (patient, intervention, comparison, and outcome) methodology. Conclusion: The experts reached a high level of consensus on many of key questions in the survey. Final key questions provide direction for developing clinical practice guideline in the immunosuppressive treatment of transplantation.
참고문헌 (19)
- Port FK, "Comparison of survival probabilities for dialysis patients vs cadaveric renal transplant recipients", JAMA, 270(11), pp.1339~1343 (1993)
- Kim SI, "A renal transplantation and hemodialysis cost-utility analysis in patients with end-stage renal disease", J Korean Soc Transplant, 24(3), pp.173~181 (2010)
- "Annual report of the transplant 2017" (2018)[URL]
- Kim SH, "Economic burden of chronic kidney disease in Korea using national sample cohort", J Nephrol, 30(6), pp.787~793 (2017)
- Legendre C, "Factors influencing long-term outcome after kidney transplantation", Transpl Int, 27(1), pp.19~27 (2014)
- Denton MD, "Immunosuppressive strategies in transplantation", Lancet, 353(9158), pp.1083~1091 (1999)
- Kalluri HV, "Current state of renal transplant immunosuppression: Present and future", World J Transplant, 2(4), pp.51~68 (2012)
- Field MJ, "Clinical practice guideline: directions for a new program", pp.8~18 (1990), National Academy Press
- Baker RJ, "Renal association clinical practice guideline in post-operative care in the kidney transplant recipient", BMC Nephrol, 18(1), pp.174~ (2017)
- "Clinical Guidelines for Kidney Transplantation" (2018)[URL]
- Kidney Disease: Improving Global Outcomes (KDIGO) Transplant Work Group, "KDIGO clinical practice guideline for the care of kidney transplant recipients", Am J Transplant, 9(Suppl 3), pp.S1~S155 (2009)
- Woolf S, "Developing clinical practice guidelines: types of evidence and outcomes; values and economics, synthesis, grading, and presentation and deriving recommendations", Implement Sci, 7, pp.61~ (2012)
- Woolf SH, "Clinical guidelines: potential benefits, limitations, and harms of clinical guidelines", BMJ, 318(7182), pp.527~530 (1999)
- Entwistle VA, "Developing information materials to present the findings of technology assessments to consumers. The experience of the NHS Centre for Reviews and Dissemination", Int J Technol Assess Health Care, 14(1), pp.47~70 (1998)
- Lee S, "ABO-incompatible kidney transplantation", Ewha Med J, 38(1), pp.7~13 (2015)
- Yoon HE, "Renal transplantation in highly sensitized recipients", J Korean Soc Transplant, 22, pp.8~12 (2008)
- 유훈, "Rituximab와 혈장교환을 사용한 ABO 혈액형 부적합 생체 신장이식: 단일 기관의 경험", Kidney Research and Clinical Practice, 30(4), pp.386~393 (2011), 대한신장학회
- Karuthu S, "Common infections in kidney transplant recipients", Clin J Am Soc Nephrol, 7(12), pp.2058~2070 (2012)
- Silkensen JR, "Long-term complications in renal transplantation", J Am Soc Nephrol, 11(3), pp.582~588 (2000)